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Background: Intracellular pathogens have devised various mechanisms to subvert the host immune response in
order to survive and replicate in host cells. Here, we studied the infection of human blood monocytes with the
intracellular pathogen C. pneumoniae and the effect on cytokine and chemokine profiles in comparison to
stimulation with LPS.
Results: Monocytes purified from peripheral blood mononuclear cells by negative depletion were infected with
C. pneumoniae. While immunofluorescence confirmed the presence of chlamydial lipopolysaccharide (LPS) in the
cytoplasm of infected monocytes, real-time PCR did not provide evidence for replication of the intracellular pathogen.
Complementary to PCR, C. pneumoniae infection was confirmed by an oligonucleotide DNA microarray for the
detection of intracellular pathogens. Raman microspectroscopy revealed different molecular fingerprints for infected
and non-infected monocytes, which were mainly due to changes in lipid and fatty acid content. Stimulation of
monocytes with C. pneumoniae or with LPS induced similar profiles of tumor necrosis factor-alpha (TNF-α)
and interleukin (IL)-6, but higher levels of IL-1β, IL-12p40 and IL-12p70 for C. pneumoniae which were statistically
significant. C. pneumoniae also induced release of the chemokines MCP-1, MIP-1α and MIP-1β, and CXCL-8, which
correlated with TNF-α secretion.
Conclusion: Infection of human blood monocytes with intracellular pathogens triggers altered cytokine and
chemokine pattern as compared to stimulation with extracellular ligands such as LPS. Complementing conventional
methods, an oligonucleotide DNA microarray for the detection of intracellular pathogens as well as Raman
microspectroscopy provide useful tools to trace monocyte infection.
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Microbial pathogens have developed various strategies
to escape and alter host immunity to favor their survival
within the host [1,2]. Intracellular pathogens, in particu-
lar, use host cells as a replicating niche, and their release
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Chlamydia pneumoniae is a Gram-negative, obligate
intracellular bacterium causing respiratory infections, such
as acute pneumonia, bronchitis, and sinusitis [3]. Further-
more, there is a growing body of evidence for association of
persistent C. pneumoniae infections with a range of chronic
diseases, such as atherosclerosis, asthma, arthritis, multiple
sclerosis, Alzheimer’s disease, and osteoporosis [4-10].
Chlamydiae exhibit a dimorphic life cycle with extracellular,
infectious elementary bodies (EBs), and intracellular, non-
infectious reticulate bodies (RBs) [11,12]. Transition into a
state of persistence can be induced in vitro by factors suchtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Among the susceptible host cells are the mucosal and vas-
cular endothelium, smooth muscle cells, circulating mono-
cytes, and tissue-specific macrophages [13]. C. pneumoniae
can induce monocyte inflammatory cascades and modulate
cellular lipid metabolism [14]. Human monocyte cell lines
have been shown to transfer the pathogen to endothelial
cells in vitro [15-17], and several lines of evidence propose
a role of circulating monocytes as vehicle of its vascular
dissemination [18]. Monocytes may traffic C. pneumoniae
across the blood-brain-barrier, shed them in the central
nervous system, and induce neuroinflammation [19,20].
The detection of pathogens within immune cells is
challenging, and their intracellular growth may prevent
correct diagnosis and appropriate treatment. The value
of blood cultures as a general diagnostic tool for patho-
gen detection is limited due to delayed availability of re-
sults and poor sensitivity for fastidious pathogens [21].
Here, we established an in vitro model for the infection
of immune cells with intracellular pathogens and investi-
gated cytokine and chemokine release from human blood
derived monocytes infected with C. pneumoniae. To trace
monocyte infection, we applied a combination of methods,
namely immunofluorescence and real-time PCR (RT-PCR)
as well as an oligonucleotide DNA microarray for intracel-
lular pathogens. Finally, we used Raman microspectroscopy
to identify infected monocytes based on altered biomol-
ecule fingerprints.
Results
Detection of C. pneumoniae by immunofluorescence
C. pneumoniae was grown in HEp-2 cells, which are estab-
lished for Chlamydia propagation [22]. Cells were lysed at
72 h post infection, and fractions of chlamydial elementary
bodies were isolated and used to infect adherent mono-
cytes. Infection was performed using 2 × 103 and 2 × 104
inclusion forming units (IFU) per 2 × 105 monocytes, fur-
ther designated as high and low dose protocols, respect-
ively. Mature chlamydial inclusions co-localized with LPS
in infected HEp-2 cells, and chlamydial DNA could be vi-
sualized at 48 h post infection (Figure 1A, upper panel). In
contrast to the clearly bordered chlamydial inclusions ob-
served in HEp-2 cells, chlamydial LPS appeared in clusters
of vesicles in the cytoplasm of monocytes (Figure 1A, mid-
dle panel). Reinfection of fresh HEp-2 cells with lysates de-
rived from infected monocytes revealed no chlamydial
inclusions (Figure 1A, lower panel), indicating the absence
of viable pathogen. Monocyte infection rates as determined
by immunofluorescence were 3–9% for the low dose vs.
41–50% for the high dose infection (Figure 1B).
Detection of C. pneumoniae by DNA-microarray and RT- PCR
Two DNA-based methods, RT-PCR and a novel DNA
microarray, were employed to monitor C. pneumoniaeinfection of monocytes. RT-PCR revealed no significant
changes in copy numbers of the intracellular pathogen
over time (Figure 1C). No chlamydial DNA was detected
in uninfected monocytes. In contrast, HEp-2 cells infected
with C. pneumoniae exhibited an increase in the copy
number of the 16S rDNA gene transcripts after 48 h of in-
fection (Figure 1D).
An oligonucleotide microarray was developed for the sim-
ultaneous detection of Bartonella, Bordetella, Chlamydia
and Mycoplasma as described in Materials and Methods.
The sequence of the chosen primer pair and oligonucleotide
probes are summarized in Figure 2A. Red spots on the
heatmap (Figure 2B) indicate strong hybridization of the
selected oligonucleotide probes with their complementary
PCR products, demonstrating the specificity of the micro-
array. Certain probes, such as Chlamydia spp. p4 showed
weak cross-hybridization to Mycoplasma and Bordetella.
To classify a hybridization pattern, the nearest shrunken
centroid classification was used and validated in a leave-
out cross-validation approach [23]. Relying on this ana-
lysis, the assay specificity for all 43 hybridizations was
determined to be 100% at genus level and more than
84.1% at species level. Using this oligonucleotide micro-
array, DNA extracted from monocytes yielded a positive
signal at 6 and 48 h post infection for the high and low
dose protocol, respectively (Figure 2C).
Detection of modified biomolecule patterns by Raman
spectroscopy
We recorded Raman spectra for monocytes infected with
C. pneumoniae and for uninfected monocytes. The scores
plot resulting after Principal Component Analysis (PCA)
showed two clusters for uninfected and infected mono-
cytes after 48 h, which can be separated on PC1 (48%),
while no separation was seen after 6 h of infection
(Figure 3A). Data of infected and uninfected cells after
48 h were compared in a mean spectra plot (Figure 3B)
and certain wave number areas specific for infection were
re-analyzed by PCA for clear separation (percentage value
on PC1 > 48%). According to this analysis, differences
between infected monocytes and uninfected control were
found in wavenumber regions 1645–1660 cm−1, 1430–
1451 cm−1, 1327–1356 cm−1, 1290–1306 cm−1, and 888–
934 cm−1, indicating changes in lipids, fatty acids, and
nucleic acids in infected monocytes [24].
Cytokine release from infected monocytes
Cytokine release was assessed after monocyte infection
with C. pneumoniae (Figure 4). Levels of tumor necrosis
factor-alpha (TNF-α) increased over 6 h after post infection
with low dose C. pneumoniae or LPS and remained
stable or slightly decreased at later time points. High dose
C. pneumoniae induced an analogous kinetic pattern of
TNF-α release with approximately five-fold higher TNF-α
Figure 1 Detection of C. pneumoniae in HEp-2 cells and monocytes using immunofluorescence microscopy and RT-PCR. A) C. pneumoniae
(green) was detected in HEp-2 cells (upper panel) and in adherent monocytes (middle panel) at 48 h post infection. Recovery of C. pneumoniae was
evaluated by recultivating disrupted monocytes at 48 h post infection in HEp-2 cells (lower panel). Cells were counterstained with Evans Blue (red),
and DNA was visualized with DAPI (blue). Chlamydial inclusions are clearly demarcated in HEp-2 cells, but appear diffuse in monocytes
(scale bar = 10 μm). B) Monocyte infection was performed using 2 × 104 IFU (open bars) and 2 × 103 IFU (hatched bars) per 2 × 105 monocytes,
respectively, and monocyte infection rates were determined by immunofluorescence. C) C. pneumoniae 16S rDNA copies in monocytes and D) HEp-2
cells infected with 2 × 104 IFU (open bars), 2 × 103 IFU (hatched bars) and uninfected cells (grey bars) were quantified at 6 and 48 h post infection by
RT-PCR. Concentrations are expressed as mean ± SD for 3 independent experiments. *P≤ 0.05
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Figure 2 Detection of C. pneumoniae by a DNA microarray for intracellular pathogens. A) Hybridization results were obtained with
genus-specific probes (p) for selected intracellular pathogens. B) Results for all hybridization experiments are represented as a heatmap.
Columns correspond to probes and rows to hybridizations. Colors correspond to signal values (green: no signal; black: weak signal; red:
strong signal). C) Specific hybridization patterns were obtained for monocytes infected with 2 × 104 IFU (open bars) and 2 × 103 IFU (hatched bars)
per 2 × 105 monocytes after 6 h (upper panel) and 48 h (lower panel) post infection with Chlamydia spp. probes. Error bars represent the mean of 4
replicate spots on the microarray. The figures show one representative microarray analysis (n = 3).
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tion for all stimuli with a continuous increase over 48 h.
High dose C. pneumoniae yielded about five-fold higher
IL-6 concentrations as compared to the lower dose.
While similar levels of TNF-α and IL-6 were released
after infection with low dose C. pneumoniae or stimula-
tion with 1 ng/mL LPS, low dose C. pneumoniae in-
duced higher levels of IL-1β, IL-12p40 and IL-12p70
over time than LPS, which was shown to be statistically
significant (Figure 4). Noteworthy, levels of IL-12p40 in
the supernatant were about ten-fold higher than levels
of IL-12p70, demonstrating that production of each of
the subunits of IL-12 is independently regulated. The
anti-inflammatory mediator IL-10 started to increase at
6 h post infection for all stimuli, but showed different
kinetics for low dose C. pneumoniae and LPS. LPSyielded significantly higher levels of IL-10 than low dose
C. pneumoniae at 6 h after stimulation, but this ratio was
reversed over time, resulting in significantly higher IL-10
levels for low dose C. pneumoniae as compared to LPS
after 48 h. Cytokine levels released from mock-infected
monocytes remained below the detection limit and did
not differ from uninfected controls (medium alone).
Chemokine release from infected monocytes
Secretion of monocyte chemotactic protein (MCP)-1 and
MCP-3 started at 24 h after monocyte infection with C.
pneumoniae and continued to increase for up to 48 h. LPS
induced significantly lower amounts of both chemokines
over time (Figure 5). Macrophage inflammatory protein
(MIP)-1α and MIP-1β release started at 6 h after mono-
cyte infection with C. pneumoniae and continued to
Figure 3 Raman Microspectroscopy of monocytes infected with C. pneumoniae. A) Score plot based on Principal Component Analysis (PCA).
Monocytes infected with C. pneumoniae for 48 h (red dots) were separated from uninfected cells (blue dots), whereas no difference was observed after
6 h of infection (orange dots) compared to control. B) Mean spectra plot of PC-1 indicating the wavenumber regions which were mainly responsible
for the differences between uninfected and infected monocytes after 48 h. Peaks shown in dark grey correspond to the wave number regions which
are mainly responsible for data separation. The percentage of data defining the separation is indicated.
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after stimulation with LPS and started to decrease there-
after. An analogous pattern was seen for IL-8 (CXCL-8),
which increased continuously over 48 h after monocyte
infection with C. pneumoniae, while levels peaked at 24 h
upon LPS stimulation. Again, chemokine levels released
from mock-infected monocytes remained below the detec-
tion limit.
Discussion
Monocytes and monocyte-derived macrophages are sup-
posed to act as vectors for the systemic dissemination of
C. pneumoniae [25]. Here, we established an in vitro
model to study the activation of human blood mono-
cytes with C. pneumoniae and to examine immune me-
diator profiles secreted by infected monocytes. To detect
intracellular pathogen and to analyze the potential ability
of monocytes to support Chlamydia replication, we
applied a combination of RT-PCR and immunofluor-
escence as well as an oligonucleotide DNA microarray
for intracellular pathogens. Immunofluorescence revealed
numerous small vesicles containing clusters of chlamydial
LPS in the cytoplasm of infected monocytes, but it
failed to detect chlamydial DNA or typical chlamydial
inclusions. HEp-2 cells, which were used to propagate
C. pneumoniae, in contrast, allowed for the formation
and growth of inclusions containing chlamydial DNA and
LPS. RT-PCR did not reveal significant changes in copy
numbers of the intracellular pathogen over time, which
indicates persistence but not replication of internalized
C. pneumoniae in monocytes under these experimentalconditions. In line with this finding, no viable C. pneumoniae
could be recovered in HEp-2 cells upon re-infection with
lysates from monocytes infected with C. pneumoniae for
48 h. This observation is in accordance with previously
published data showing that C. pneumoniae does not
replicate in freshly isolated monocytes, while monocyte-
derived macrophages cultured for several days support
the growth of chlamydial progeny [26,27]. Consistently,
a comparative evaluation of monocyte infection with
C. pneumoniae [28] showed a drastically reduced infect-
ivity of C. pneumoniae in human monocytes at 24 and
48 h after infection, and no infective C. pneumoniae was
detectable at later time points.
Complementary to immunofluorescence and RT-PCR,
we confirmed the presence of C. pneumoniae in infected
monocytes using an oligonucleotide DNA microarray
for the detection of intracellular pathogens Bartonella,
Bordetella, Chlamydia and Mycoplasma. DNA extracted
from monocytes infected with C. pneumoniae yielded a
positive signal at 6 and 48 h post infection for the high
and low dose protocol, suggesting that the prototype
DNA array has a potential to be developed into a useful
diagnostic tool.
As a further method to trace monocyte infection with
C. pneumoniae, we assessed the ability of Raman micro-
spectroscopy to discriminate between infected mono-
cytes and non-infected cells. Raman microspectroscopy,
a combination of Raman spectroscopy and confocal mi-
croscopy, is an emerging technique to study living cells,
providing fingerprints of their chemical composition.
It has been applied in a recent study to characterize
Figure 4 Cytokine induction in monocytes infected with C. pneumoniae or stimulated with LPS from E. coli. Human adherent monocytes
(2 × 105/well of 24 well plates) were infected with 2 × 104 (open bars) or 2 × 103 (hatched bars) inclusion forming units of C. pneumoniae
or stimulated with 1 ng/ml LPS (black bars) for 3, 6, 24, and 48 h. Medium alone served as negative control (grey bars). Mock controls
did not differ from the values obtained for “medium alone”. Concentrations are expressed as mean ± SD for 3 independent experiments. *P≤ 0.05.
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infected epithelial cells [29]. According to our results,
this non-invasive technique allows for the discrimin-
ation of C. pneumoniae infected and non-infected
monocytes, supporting its value to screen for intracellu-
lar pathogens. Of note, the changes in the wave num-
ber regions 1645–1660 cm−1 (unsaturated lipids) and
1327–1356 cm−1 (adenine) in infected monocytes in our
study were comparable to data obtained in chlamydial in-
fected epithelial cells [29].Cytokine and chemokine release from infected mono-
cytes were assessed in comparison to mediator release
triggered by LPS. While several studies have been pub-
lished on cytokine release by monocytic cell lines in-
fected with C. pneumoniae [30,31], we used human blood
monocytes purified from human peripheral blood mono-
nuclear cells (PBMCs) by negative depletion and adher-
ence to tissue culture plates. While release of TNF-α and
IL-6 did not differ significantly for stimulation with low
dose C. pneumoniae and LPS, C. pneumoniae induced
Figure 5 Chemokine induction in monocytes infected with C. pneumoniae or stimulated with LPS from E. coli. Human adherent monocytes
(2 × 105/well of 24 well plates) were infected with 2 × 104 (open bars) or 2 × 103 (hatched bars) inclusion forming units of C. pneumoniae or stimulated
with 1 ng/ml LPS (black bars) for 3, 6, 24 and 48 h. Medium alone served as negative control (grey bars). Mock controls did not differ from the values
obtained for “medium alone”. Concentrations are expressed as mean ± SD for 3 independent experiments. *P≤ 0.05.
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IL-12p70 than lipopolysaccharide. Secretion of IL-1β is
tightly controlled and requires a first danger signal to pro-
duce pro-IL-1β and a second intracellular signal to induce
caspase-1 dependent secretion of mature IL-1β [32,33].
Due to constitutive activation of caspase-1, monocytes are
able to secrete IL-1β upon stimulation with single ligands,
while this ability is lost after monocyte adhesion [34].
Consistently, adherent monocytes in our study failed to
release significant amounts of IL-1β upon stimulation with
LPS alone, whereas infection with C. pneumoniae, which
provides both an extracellular and an intracellular stimu-
lus, resulted in strong induction of IL-1β. The same pat-
tern was observed for IL-12, confirming that TLR ligandsalone are not sufficient to induce production of the IL-12
heterodimer [35].
Infection with C. pneumoniae induced substantial che-
mokine release from adherent monocytes in our model.
MCP-1, MIP-1α, and IL-8 secretion were comparable
for low-dose chlamydial infection and stimulation with
LPS, correlating with similar TNF-α secretion for the
two stimuli, adding evidence to the finding that MCP-1,
MIP-1α and IL-8 induction depend on TNF-α [36].
Conclusion
The intracellular pathogen C. pneumoniae could be detected
in human blood monocytes using a combination of im-
munofluorescence and RT-PCR, but we found no evidence
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DNA microarray for the detection of intracellular patho-
gens as well as Raman microspectroscopy provided robust
values to track infection of immune cells with intracellular
pathogens. Infection of human blood monocytes with
C. pneumoniae resulted in cytokine and chemokine pro-
files which differed significantly from stimulation with
LPS, underscoring the ability of intracellular pathogens to
alter innate immune response and to enhance mediator
release via simultaneous activation of both membrane-
bound and cytosolic pattern recognition receptors.Materials and methods
Cell culture media and reagents
Phosphate-buffered saline (PBS), Eagle’s minimum essen-
tial media (MEM) GlutaMAX, gentamicin/amphotericin B
solution were obtained from Invitrogen (Lofer, Austria).
RPMI-1640, MEM non-essential amino acid, human male AB
serum (sterile-filtered), cycloheximide, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), fetal bovine serum
(FBS), and lipopolysaccharide (LPS) from E. coli (055:B5,
purified by gel filtration) were purchased from Sigma-
Aldrich (St Louis, MO, USA). Fluorescein isothiocyanate
(FITC)-conjugated anti-CD45 monoclonal antibody (mAb),
R-phycoerythrin (PE)-conjugated CD14 mAb and the re-
spective IgG control antibodies were from Becton Dickinson
(Vienna, Austria).Propagation of C. pneumoniae
C. pneumoniae strain CWL-029 was obtained from the
American Type Culture Collection (ATCC, VR-1310)
and propagated in HEp-2 cells (ATCC, CCL23) as previ-
ously reported [22,37,38]. In brief, HEp-2 cells were pas-
saged in Eagle’s MEM GlutaMAX supplemented with
10 μg/ml gentamicin, 0.25 μg/ml amphotericin B,
1 vol% MEM non-essential amino acids and 10 vol% heat-
inactivated FBS. Confluent monolayers were infected with
C. pneumoniae and grown in the medium described above
containing 1 μg/mL cycloheximide, but lacking antibiotics.
Cells were spun at 1700 g for 1 h at 35°C to enhance in-
fectivity. At 72 h post infection (hpi) at 35°C and 5% CO2,
the cell monolayer was disrupted using a cell scraper and
zirconium dioxide beads. Chlamydial EBs were obtained
by sequential centrifugation of the lysates at 600 g
(10 min) and at 30,000 g (1 h; 4°C). The pelleted EBs
were suspended in sucrose-phosphate-glutamic acid buffer
(0.2 M sucrose, 3.8 mM KH2PO4, 7.2 mM Na2HPO4,
5 mM L-glutamic acid, pH 7.4) and stored at −80°C. The
number of chlamydial inclusion forming units (IFU) per
mL was determined by infectivity titration of EBs in
HEp-2 cells for 48 h at 35°C, followed by immunofluores-
cence staining as described below. To exclude myco-
plasma contamination, cell culture and chlamydial stockswere regularly tested using the Venor™GeM Mycoplasma
Detection Kit (Minerva Biolabs, Berlin, Germany).
Isolation and culture of monocytes
PBMCs were isolated from leukocyte reduction system
(LRS) chambers of a TrimaAccel® blood collector after
approval by the ethics committee of the Medical Univer-
sity Vienna and written informed consent were obtained
from all participants (ECS2177/2013). Blood from LRS
chambers was diluted 1:8 (vol/vol) with PBS containing
2 mM ethylene diamine tetraacetic acid (PBS/EDTA),
and PBMCs were enriched by Ficoll gradient centrifuga-
tion. Monocytes were isolated by negative depletion with
the monocyte isolation kit II (Miltenyi Biotec, Bergisch
Gladbach, Germany) yielding >80% CD14 positive cells
as confirmed by flow cytometry. Viability was >95% as
determined by exclusion of 7-ADD.
Monocytes were resuspended at a concentration of
4 × 105/mL in serum-free RPMI-1640 supplemented
with 20 mM HEPES and cultured as described [39]. Ali-
quots of 0.5 mL/well of the monocyte suspension were
seeded onto 24 well flat-bottomed tissue culture plates
(Corning Incorporated, NY, USA). After 3 h at 37°C, the
monocyte monolayer was gently washed with serum-free
RPMI-1640 to remove non-adherent cells. Adherent mono-
cytes were kept in RPMI-1640 medium complete contain-
ing 20 mM HEPES and 10 vol% human AB serum for an
additional 24 h at 37°C.
Infection of adherent monocytes
Adherent monocytes were inoculated with 2 × 103 or
2 × 104 chlamydial IFU/well, respectively, or with 1 ng/
mL LPS (positive control) in a final volume of 0.5 mL
medium complete. For infection, cells were centrifuged
30 min at 600 g and incubated at 37°C in 5% CO2. Cu-
mulative culture supernatants were collected after 3, 6,
24 and 48 h, respectively, without replacing with fresh
media, centrifuged at 600 g for 5 min at 4°C, and stored
at −80°C until quantification of cytokines. Mock controls
were prepared following the propagation, harvest and
purification procedure for EBs [40,41], but in the ab-
sence of chlamydial infection.
Recovery assay
The monocyte monolayer exposed to C. pneumoniae for
6 and 48 h was washed with PBS, and cells were scraped
and vortexed with zirconium dioxide beads. EBs were
obtained from the lysates as described above and pas-
saged onto HEp-2 cells. At 48 hpi, HEp-2 cells were
fixed and stained for immunofluorescence as described.
DNA isolation and quantification
Adherent monocytes infected with C. pneumoniae for 6
and 48 h or uninfected cells were washed with PBS and
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Total genomic DNA was isolated and purified using
the QIAmp Mini DNA kit (Qiagen, Hilden, Germany).
Purified DNA was quantified at 485/530 nm using the
Quant-iTdsDNA HS assay and the Qubit™ fluorometer
(Invitrogen, Lofer, Austria).
Real-time quantitative PCR
C. pneumoniae genomes were quantified by real-time
quantitative PCR, targeting a 222 bp sequence present
on Chlamydia 16S rDNA. The oligonucleotide primers
and TaqMan probes were synthesized by Microsynth AG
(Balgach, Switzerland) and used as described in detail
previously [42]. RT-PCR was performed in a final vol-
ume of 20 μL including 1x Master Mix and Taq poly-
merase (Mastermix 16S, Molzym, Bremen, Germany),
forward primer (0.75 μM), reverse primer (0.75 μM),
FAM-TAMRA probe (0.75 μM) and 2 ng of DNA. Amp-
lification and detection was performed for 10 min at 95°C,
followed by 50 cycles of 10 s at 95°C and 65 s at 60°C.
Standards of known concentration (101, 102, 103, 104, 105
and 106 copies) were prepared for the 16S rDNA target
gene from PCR amplified C. pneumoniae DNA by con-
ventional PCR, and purified with a QIAmp Mini DNA kit,
according to the manufacturer’s instructions. Samples
were run in triplicate and all reactions were carried out
using the iCycler IQ system (BioRad, Vienna, Austria).
Detection of intracellular pathogens by DNA microarray
In addition to RT-PCR, a prototype oligonucleotide micro-
array was developed. DNA amplification and labeling was
carried out with one universal primer pair targeting a
specific region of the 16S rRNA gene. Hybridization
was performed with novel probes for Bartonella, Bordetella,
Chlamydia and Mycoplasma, which were designed and
modified as described [23,43]. Four replicates of each
probe at a concentration of 50 μM were printed onto
silylated glass slides with reactive aldehyde groups (CSS-
100 Silylated Slides; CEL Associates, Texas, USA) by the
contact arrayer Omnigrid from GeneMachines (San Carlos,
CA, USA) with MP 3 pins (TeleChem, Sunnyvale, CA,
USA) leading to spot size of 100 μm. A hybridization con-
trol probe (5’ –TTA AAA CGA CGG CCA GTG AGC)
was spotted on the array applying the same conditions as
used for the target capture probes. DNA amplification and
primer extension were performed according to [23] with
modifications as described in detail in Additional file 1.
Slides were scanned using an Axon Genepix 4000A micro-
array scanner (Axon, Union City, California) and data were
analyzed as described [23].
Raman microspectroscopy
Monocytes infected with C. pneumoniae (2 × 104 IFU)
were cultured for 6 and 48 h on glass bottom μ-slides(170 μm thickness; ibidi GmbH, Munich, Germany).
Samples were fixed with 4% paraformaldehyde for 4 min
and washed 3 times with PBS. Raman spectroscopy was
performed by CellTool (Bernried, Germany) using the
Bio-Ram® system and the Bio-Ram® software. Raman spec-
tra of 60 cells per assay were recorded with a 785 nm laser
(80 mW), applying an accumulated time of 3 × 10 sec.
Data of the biologically relevant region (700–3000 cm−1)
were pre-treated with a median filter for noise reduction,
unit vector normalisation and subsequent multivariate
data analysis were done with the statistical software the
Unscrambler X 10.3 (Camo Software, Oslo, Norway). We
performed Principle Component Analysis (PCA) using the
NIPALS algorithm and cross validation, which is a com-
mon procedure for spectral data analysis.Quantification of cytokines and chemokines
The levels of tumor necrosis factor-alpha (TNF-α), inter-
leukin (IL)-1β, IL-6, IL-12p70, IL-12p40, IL-10, monocyte
chemotactic protein (MCP)-1 (CCL-2), MCP-3 (CCL-7),
macrophage inflammatory protein (MIP)-1α (CCL-3),
MIP-1β (CCL-4), and IL-8 (CXCL-8) were determined
in culture supernatants using the Bio-Plex 200 system
(Bio-Rad, Vienna, Austria).Immunofluorescence
Infected HEp-2 cells or monocytes were cultured on
μ-slides (ibidi GmbH, Munich, Germany) at 6 or 48 hpi,
washed with PBS and fixed in 0.5 mL of methanol for
10 min. To visualize chlamydial inclusions, cells were
stained with FITC-conjugated anti-Chlamydia-LPS mAb
and human cells were counterstained with Evans Blue
(Pathfinder, Chlamydia Culture Confirmation System,
Bio-Rad, Vienna, Austria). The cells were mounted in
Fluoromount-GTM containing DAPI (Southern Biotech,
Birmingham, UK) and fluorescence images were acquired
with a Zeiss LSM 700 laser scanning confocal microscope
(Carl Zeiss SAS, Jena, Germany) using a 40x oil objective/
1.3 NA or 63x oil objective/1.4 NA.Flow cytometry
Purity and viability of monocytes were examined by deter-
mination of CD14 positive cells and 7-aminoactinomycin
D (7-AAD) exclusion. Monocytes were stained with un-
conjugated 7-AAD (BioLegend, Fell, Germany), FITC-
conjugated anti-CD45 and PE-conjugated CD14 or with
the respective IgG control antibody in PBS supplemented
with 2 vol% FBS, 0.1 w% sodium azide at 4°C for 30 min.
After one washing step, cells were analyzed on a Beckman
Coulter FC 500 flow cytometer (Beckman Coulter, Vienna,
Austria) and data were analyzed using the FlowJo software
(Tree Star Inc, Ashland, OR).
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Statistical analysis was performed using the software
package SPSS Statistics for Windows, version 18.0 (SPSS
Inc., Chicago, Illinois, USA). When comparing two groups,
data were analyzed by the nonparametric Wilcoxon rank
sum test. Data are expressed as means ± SD. Significance
was accepted at P ≤ 0.05.Additional file
Additional file 1: Materials and methods of the DNA microarray
analysis.Competing interests
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